Alignment Healthcare (ALHC) investor relations material

Executive summary

• Annual Meeting scheduled for June 4, 2026, to be held virtually; record date is April 6, 2026.

• Focus on delivering high-quality, cost-effective Medicare Advantage care, leveraging proprietary technology and a senior-first culture.

• 2025 saw strong financial and operational performance: 25% membership growth, 46% revenue growth, positive operating cash flow, and improved profitability.

• All members enrolled in 4-Star or better plans for the second consecutive year; recognized as one of Fortune World's Most Admired Companies.

Voting matters and shareholder proposals

• Proposal 1: Election of three Class II directors (Jody Bilney, David Hodgson, Jacqueline Kosecoff) for terms expiring in 2029.

• Proposal 2: Ratification of Deloitte & Touche LLP as independent auditor for 2026.

• Proposal 3: Advisory vote on executive compensation (say-on-pay).

• Board recommends voting FOR all proposals.

Board of directors and corporate governance

• Board consists of nine directors, with 7 of 9 and all committee members independent.

• Board divided into three classes with staggered terms; robust diversity in gender, ethnicity, and experience.

• Lead Independent Director role established to enhance independent oversight.

• Annual board and committee self-assessments, ongoing refreshment, and strong stockholder engagement.

• Code of Conduct, insider trading policy, and stock ownership guidelines in place.